Metformin, a biguanide antihyperglycemic agent, prevents angiotensin II (AngII)-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient (ApoE−/−) mice. The gene discussed is APOE; the disease is abdominal aortic aneurysm.